Philadelphia-based Penn Medicine has extended the appointment of CEO Kevin Mahoney through June 2031.
Mr. Mahoney has led the University of Pennsylvania Health System since July 2019, a health system spokesperson said in a June 9 statement shared with Becker’s. He has advanced Penn Medicine’s strategic direction by expanding access points, building a sustainable workforce pipeline and advocating for safer care environments for team members, the spokesperson said.
Mr. Mahoney said in a statement shared with Becker’s that it has been a privilege to serve the Penn Medicine mission for 30 years.
“Penn Medicine is an extraordinary institution, defined by the talent and commitment of its people,” Mr. Mahoney said. “Our clinicians and scientists are turning new ideas into care that improves lives today and sets the direction for what medicine can become. I’m profoundly grateful to be part of this community.”
Mr. Mahoney joined the system in 1996 and previously served as executive vice president and chief administrative officer.
Penn Medicine includes the University of Pennsylvania Health System and the Raymond and Ruth Perelman School of Medicine in Philadelphia.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
